All these steps are important milestones in the process. Getting the IND approved and kicking off the human trials would be a huge step for this company.
Will Bintai Kinden really come through with the financing to do the trials?
Is the SEC slow rolling the NGIO S-1? Why?
(5)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links